company
Tessel Bio
Tessel Bio is a company that applies AI to drug development. It announced Sesame, AI for generative chemistry, on 24 Jun 2026.
Key facts
- Product announcement
- Announcing Sesame: Frontier AI for generative chemistry (24 Jun 2026)source
- Collaboration
- Tessel and Sanofi collaborate on AI for target discovery (05 Jan 2026)source
- Collaboration
- Tessel and Century Health collaborate to accelerate drug development (18 Dec 2025)source
- Award
- Tessel awarded up to $4.2M by ARPA-H (10 Dec 2025)source
WYDE coverage of Tessel Bio
Sources
Track the institutions that move money.
Data-driven coverage every Friday.